Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Nonalcoholic Steatohepatitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01894438
What this trial is testing

Mediterranean Lifestyle Intervention in Patients With Non-alcoholic Fatty Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver Disease (NAFLD)Non-alcoholic Steatohepatitis (NASH)
Harokopio University 63
Post-approval studies (Phase 4)UnknownNCT02964715
What this trial is testing

The Effect of Empagliflozin on NAFLD in Asian Patients With Type 2 Diabetes

Who this might be right for
Type2 DiabetesNAFLD
University of Malaya 25
Not applicableStudy completedNCT04791397
What this trial is testing

Evaluation of the Effect of IHHT on Vascular Stiffness and Elasticity of the Liver Tissue in Patients With MS.

Who this might be right for
Vascular StiffnessLiver FibrosesMetabolic Syndrome+2 more
I.M. Sechenov First Moscow State Medical University 62
Testing effectiveness (Phase 2)Ended earlyNCT02029586
What this trial is testing

Therapeutic Exploratory Phase 2 Study to Evaluate the Safety and Efficacy of MB12066 in Patients With Nonalcoholic Fatty Liver Disease(NAFLD) Except Cirrhosis

Who this might be right for
Nonalcoholic Fatty Liver Disease
Yungjin Pharm. Co., Ltd. 18
Post-approval studies (Phase 4)Study completedNCT03910361
What this trial is testing

Efficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver Diseases

Who this might be right for
Type2 DiabetesNon-Alcoholic Fatty Liver Disease
Dong-A ST Co., Ltd. 51
Testing effectiveness (Phase 2)Study completedNCT07104786
What this trial is testing

Comparison of Effectiveness of Obeticholic Acid With Vitamin E in Patients of Non-alcoholic Fatty Liver Disease

Who this might be right for
Non Alcoholic Fatty Liver Disease
King Edward Medical University 90
Post-approval studies (Phase 4)UnknownNCT05140694
What this trial is testing

Effect of Empagliflozin and Dulaglutide on MAFLD in Patients With T2D

Who this might be right for
Metabolic-associated Fatty Liver DiseaseType 2 Diabetes
Seoul National University Bundang Hospital 135
Testing effectiveness (Phase 2)Study completedNCT02019056
What this trial is testing

Efficacy and Safety of MG in the Patients With Alcoholic Fatty Liver Disease and Alcoholic Hepatitis

Who this might be right for
Alcoholic Fatty Liver DiseaseAlcoholic Hepatitis
PharmaKing 90
Testing effectiveness (Phase 2)UnknownNCT05784779
What this trial is testing

Phase Ib/II Study to Evaluate the Efficacy and Safety of GH509 Versus Placebo in Patients With NASH/NAFLD

Who this might be right for
NASHNAFLD
1Globe Biomedical Co., Ltd. 180
Testing effectiveness (Phase 2)Study completedNCT02421094
What this trial is testing

Clinical Trial to Evaluate Efficacy of GR-MD-02 for Treatment of Liver Fibrosis in Patients With NASH With Advanced Fibrosis

Who this might be right for
Nonalcoholic Steatohepatitis
Galectin Therapeutics Inc. 30
Early research (Phase 1)Study completedNCT05117489
What this trial is testing

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Patients With Presumed Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Corcept Therapeutics 70
Not applicableStudy completedNCT00930384
What this trial is testing

A Case Control Study Evaluating the Prevalence of Non-Alcoholic Fatty Liver Disease Among Patients With Psoriasis

Who this might be right for
PsoriasisNonalcoholic Fatty Liver Disease
George Washington University 150
Testing effectiveness (Phase 2)Study completedNCT03061721
What this trial is testing

Saroglitazar Magnesium in Patients With Nonalcoholic Fatty Liver Disease and/or Nonalcoholic Steatohepatitis

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNonalcoholic Steatohepatitis
Zydus Therapeutics Inc. 106
Post-approval studies (Phase 4)UnknownNCT03604016
What this trial is testing

Study to Assess Efficacy of Besifovir and L-carnitine in Chronic Hepatitis B Patients With Nonalcoholic Fatty Liver

Who this might be right for
Hepatitis B
IlDong Pharmaceutical Co Ltd 76
Not applicableWithdrawnNCT03962608
What this trial is testing

Safety and Tolerability of Yaq-001 in Patients With Non-Alcoholic Steatohepatitis

Who this might be right for
Non-Alcoholic Steatohepatitis
Yaqrit Ltd
Large-scale testing (Phase 3)Active Not RecruitingNCT04951219
What this trial is testing

Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Madrigal Pharmaceuticals, Inc. 810
Not applicableStudy completedNCT02642172
What this trial is testing

Prebiotics in Patients With Non-alcoholic Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver DiseaseMetabolic Syndrome
Kaplan Medical Center 24
Not applicableActive Not RecruitingNCT04835831
What this trial is testing

Interest of APA in Fatty Liver Disease Evaluation of Efficacy and Adherence to an Adapted Physical Activity (APA) Program in Patients With Metabolic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver Disease (NAFLD
Centre Hospitalier Universitaire de Nice 115
Not applicableStudy completedNCT07768657
What this trial is testing

Improvement in Hepatic Function Through Sumac (Rhus Coriaria L.) Supplement Along With a Calorie-restricted Diet for the Management of Grade-I Obese Non-alcoholic Fatty Liver Disease Patients

Who this might be right for
Liver BiomarkersLipid ProfileGlucose+1 more
University of Lahore 102
Not applicableStudy completedNCT05844137
What this trial is testing

Improving Detection and Evidence-based Care of NAFLD in Latinx and Black Patients With Type 2 Diabetes

Who this might be right for
NAFLDDiabetes Mellitus
Duke University 10
Next Page